Downregulation of VDR expression and secondary reduction in NRF-2 antioxidant activity have also been demonstrated in patients with chronic obstructive pulmonary disease [57] and linked to other inflammatory conditions that involve NRF-2 pathways in neural, renal, and hepatic tissues [58,59]. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.